Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers.
Lashen A, Al-Kawaz A, Jeyapalan JN, Alqahtani S, Shoqafi A, Algethami M, Toss M, Green AR, Mongan NP, Sharma S, Akbari MR, Rakha EA, Madhusudan S.
Lashen A, et al. Among authors: al kawaz a.
Neoplasia. 2024 Jan;47:100957. doi: 10.1016/j.neo.2023.100957. Epub 2023 Dec 21.
Neoplasia. 2024.
PMID: 38134458
Free PMC article.